- Home
- MNKD vs OMCL Comparison
MNKD vs OMCL Comparison
Compare MNKD & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- OMCL
- Stock Information
- Founded
- MNKD 1991
- OMCL 1992
- Country
- MNKD United States
- OMCL United States
- Employees
- MNKD N/A
- OMCL N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- OMCL Computer Manufacturing
- Sector
- MNKD Health Care
- OMCL Technology
- Exchange
- MNKD Nasdaq
- OMCL Nasdaq
- Market Cap
- MNKD 1.4B
- OMCL 1.8B
- IPO Year
- MNKD 2004
- OMCL 2001
- Fundamental
- Price
- MNKD $5.93
- OMCL $45.29
- Analyst Decision
- MNKD Strong Buy
- OMCL Buy
- Analyst Count
- MNKD 5
- OMCL 8
- Target Price
- MNKD $8.80
- OMCL $36.17
- AVG Volume (30 Days)
- MNKD 2.8M
- OMCL 424.0K
- Earning Date
- MNKD 11-05-2024
- OMCL 10-31-2024
- Dividend Yield
- MNKD N/A
- OMCL N/A
- EPS Growth
- MNKD N/A
- OMCL N/A
- EPS
- MNKD 0.04
- OMCL N/A
- Revenue
- MNKD $248,374,000.00
- OMCL $1,080,449,000.00
- Revenue This Year
- MNKD $45.87
- OMCL N/A
- Revenue Next Year
- MNKD $17.07
- OMCL $4.85
- P/E Ratio
- MNKD $136.64
- OMCL N/A
- Revenue Growth
- MNKD 57.08
- OMCL N/A
- 52 Week Low
- MNKD $3.17
- OMCL $25.12
- 52 Week High
- MNKD $6.44
- OMCL $56.06
- Technical
- Relative Strength Index (RSI)
- MNKD 58.94
- OMCL 69.83
- Support Level
- MNKD $5.95
- OMCL $42.92
- Resistance Level
- MNKD $6.26
- OMCL $45.84
- Average True Range (ATR)
- MNKD 0.29
- OMCL 1.33
- MACD
- MNKD 0.06
- OMCL -0.42
- Stochastic Oscillator
- MNKD 61.07
- OMCL 85.82
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.